Trials / Conditions / Amyloidosis in Transthyretin (TTR)
Amyloidosis in Transthyretin (TTR)
4 registered clinical trials studyying Amyloidosis in Transthyretin (TTR) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Comprehensive Program for Hereditary Transthyretin Amyloidosis NCT07213297 | Hospital de Alta Complejidad en Red | — |
| Not Yet Recruiting | To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM ( NCT07116473 | Eidos Therapeutics, a BridgeBio company | Phase 3 |
| Active Not Recruiting | Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis. NCT07080268 | Hospital General de Niños Pedro de Elizalde | — |
| Completed | Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy NCT01623245 | Thibaud Damy | — |